Flex Ltd. entered into an agreement to sell $2.0 billion of Series A Convertible Preferred Stock in its Cloud and Power Infrastructure subsidiary, Axiom Solutions International, to a group led by General Catalyst and Koch Equity Development. The proceeds will fund Axiom's acquisition of EPC Power Corp and support its balance sheet ahead of a planned spin-off into an independent public company in Q1 2027. Flex is guaranteeing the investment, which includes a redemption obligation if the spin-off is not completed by the end of 2027.
Value
$2B
Counterparty
General Catalyst
“This investment provides equity funding for our recently announced acquisition of EPC Power and will allow Axiom to have a strong balance sheet as we prepare to stand up as an independent, publicly traded company squarely focused on the power, thermal, and compute infrastructure the AI era demands.”
Revathi Advaithi, Chief Executive Officer of Flex and expected Chief Executive Officer of Axiom
“Axiom sits at the center of the power and infrastructure buildout that AI demands, and we’ve been impressed by the team’s execution and the scale of the opportunity ahead.”
Hemant Taneja, Chief Executive Officer, General Catalyst
Strategy Inc reported that between October 1 and October 4, 2026, it sold 92,894 shares of Class A Common Stock under its at-the-market (ATM) offering program for net proceeds of $15.7 million. The company utilized these proceeds, along with existing cash, to acquire 334 additional bitcoins for approximately $28.7 million, bringing its total holdings to 848,000 bitcoins.
Bluerock Acquisition Corp. II Capital Raise of $178M
Bluerock Acquisition Corp. II completed its IPO of 17,250,000 units at $10.00 per unit, including the full exercise of the over-allotment option, generating $172.5 million in gross proceeds. Simultaneously, the company raised an additional $5.81 million through a private placement of warrants to its sponsor and underwriters. A total of $173.36 million was placed into a trust account following the closing.
Blackstone Private Equity Strategies Fund Capital Raise
Blackstone Private Equity Strategies Fund (BXPE) announced the launch of a continuous private offering of new series of limited partnership units, including Class I-Series IV, Class I-Series E, Class S-Series E, Class D-Series E, and Class N-Series E. In connection with the offering, the fund amended its investment management agreement to reflect the new unit series and their applicable management fee structures.
ISQ Open Infrastructure Co Capital Raise of $23.7M
ISQ Open Infrastructure Company LLC issued and sold unregistered shares across multiple classes for total aggregate net consideration of approximately $23.67 million as of September 1, 2026. The proceeds were raised from investors for cash and as compensation for services rendered by independent directors. The company also provided updates on its monthly Transactional Net Asset Value and declared distributions for various share classes.
Pimco Asset-Based Lending Co Capital Raise of $59.1M
PIMCO Asset-Based Lending Company LLC issued and sold unregistered limited liability company interests to third-party investors for approximately $59.1 million in aggregate consideration. The offering included multiple share classes, such as Anchor I, Anchor II, and Standard A shares, priced based on the company's transactional net asset value. The company also declared monthly distributions for September 2026 across all share classes.
HarbourVest Private Equity Secondaries Fund Capital Raise of $79.3M
HarbourVest Private Equity Secondaries Fund (TE) L.P. reported that its broader fund complex issued interests for aggregate consideration of approximately $79.3 million on September 29, 2026. The Fund specifically sold 3,975 Class I Units at a transactional net asset value of $10.06 per unit as part of its continuous private offering to accredited investors and qualified purchasers.
HarbourVest Private Equity Secondaries Fund Capital Raise of $79.3M
HarbourVest Private Equity Secondaries Fund L.P. sold unregistered Class I limited partnership units for $2.15 million as part of its continuous private offering. Across the broader HSEC Fund Complex, the fund and its parallel entities issued interests for aggregate consideration of approximately $79.3 million. The units were priced at a transactional net asset value of $12.00 per unit as of August 31, 2026.
Muzinich Corporate Lending Income Fund Capital Raise of $3M
Muzinich Corporate Lending Income Fund, Inc. sold approximately $3.0 million worth of common stock in an unregistered private placement on October 1, 2026. The shares were sold at a price equal to the company's net asset value (NAV) per share as of September 30, 2026, which is currently being determined.
Surrozen announced that the FDA clearance of its IND application for SZN-8141 triggered a second closing milestone under a previously announced private placement. This second tranche is expected to provide approximately $95.1 million in gross proceeds on or about October 20, 2026, to support clinical development and operations.
Stellus Private Credit BDC Capital Raise of $10.2M
Stellus Private Credit BDC conducted a capital drawdown from investors, issuing 655,739 shares for $10 million on September 15, 2026, and an additional 13,060 shares for approximately $0.2 million on September 29, 2026. The unregistered sales were conducted via private placement under subscription agreements to fund the company's investment operations.
Pyxis Oncology closed an underwritten public offering of 36,047,919 shares of common stock and pre-funded warrants, along with accompanying common warrants, at a combined price of $2.90 per share. The offering raised approximately $110 million in gross proceeds before expenses. The common warrants will only become exercisable upon stockholder approval of a charter amendment to increase the company's authorized share count.
CNL Strategic Residential Credit Capital Raise of $6.73M
CNL Strategic Residential Credit, Inc. raised approximately $6.73 million in a private offering during September 2026. The company issued 273,277 shares of Class FA common stock and 4,008 shares of Class E common stock under Rule 506(c) of Regulation D. No selling commissions or managing dealer fees were paid in connection with these specific sales.
Veritone, Inc. is conducting a registered direct offering of 20,000,000 shares of its common stock to certain purchasers. The offering is being made under an existing shelf registration statement on Form S-3 and a related prospectus supplement.
Accelevation Holdings Corp. closed its initial public offering (IPO) of 30,000,000 shares of Class A common stock at a price of $18.00 per share. The offering consisted of 10,000,000 shares sold by the company and 20,000,000 shares sold by selling stockholders, raising $180 million in gross proceeds for the company and $360 million for the selling stockholders.
Value
$540M
Counterparty
Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC
Carlyle Private Equity Partners Fund Capital Raise of $300M
Carlyle Private Equity Partners Fund, L.P. sold unregistered limited partnership units to investors for aggregate consideration of approximately $299.9 million on September 1, 2026. The sale was conducted as part of the Fund's continuous private offering across multiple unit classes, including Class E-A, E-I, S, I, and C.
Jefferies Credit Partners BDC Capital Raise of $106M
Jefferies Credit Partners BDC Inc. completed an unregistered sale of approximately 7.44 million Class I common shares to third-party investors. The transaction generated gross proceeds of approximately $106.5 million based on the company's net asset value (NAV) per share as of August 31, 2026. The offering was conducted as a private placement exempt from registration under Section 4(a)(2) and Regulation D/S.
Warburg Pincus Access Fund, L.P. sold unregistered limited partnership units for aggregate consideration of approximately $12.0 million on September 1, 2026. The sale was conducted as part of the Fund's continuous private offering and included Class B1, B3, and E units sold at their respective Transactional NAVs.
Alpha Modus Holdings closed a PIPE transaction with non-U.S. investors, issuing 51,621,560 shares and warrants in exchange for 3,170 bitcoin valued at over $250 million. The company believes this capital raise restores its compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million, addressing a previous deficiency notice.
Banzai International entered into a subscription agreement with its CEO and Chairman, Joseph Davy, for the private placement of 115,965 shares of Class B Common Stock. The shares were sold at $0.70 per share for an aggregate cash purchase price of approximately $81,176. Following the transaction, Mr. Davy maintains a 25.6% voting interest in the company.
Veritone, Inc. entered into a securities purchase agreement for a registered direct offering of 20,000,000 shares of common stock at an implied price of $0.75 per share. The company expects to raise $15.0 million in gross proceeds to repay or restructure convertible debt and for general corporate purposes. The offering is expected to close on or about October 2, 2026.
Brightline Interactive closed a private investment in public equity (PIPE) raising $1.25 million in gross proceeds through the issuance of units of common stock and warrants. The financing was led by drone industry executive Dr. Allan Evans in his personal capacity to support the development of the SpatialCore Physical AI platform.
Brookfield Asset Management announced the final close of Oaktree’s inaugural Asset-Backed Finance Fund (ABF I) with $2 billion in total commitments. The fund reached its target raise with support from a globally diversified base of institutional investors, including sovereign wealth funds and U.S. public pension plans.
Sagimet Biosciences Inc. entered into an underwriting agreement for a public offering of 8,750,010 shares of Series A common stock at $10.00 per share and 2,750,010 pre-funded warrants at $9.9999 per share. The company expects to receive net proceeds of approximately $107.5 million, which will be used to fund a Phase 3 clinical trial for denifanstat in acne and other clinical development programs.
Solana Company entered into a securities purchase agreement for a $15 million registered direct offering of 4,369,356 shares of Class A common stock and accompanying warrants. The shares were priced at $3.433 per share, representing a 5% premium to the company's Net Asset Value. Proceeds will be used to accumulate SOL, fund working capital, and support strategic initiatives including potential stock buybacks.
KLX Energy Services Holdings Capital Raise of $37.2M
KLX Energy Services completed a subscription rights offering and a related backstop exchange, issuing approximately 25 million shares for $37.2 million in gross proceeds. Additionally, the company issued 59.3 million shares to backstop parties in exchange for reducing the outstanding principal of its 2030 Notes by $94 million. Proceeds will be used for general corporate purposes and to redeem a portion of the 2030 Notes at par.
Immix Biopharma priced an underwritten public offering of 11,363,637 shares of common stock at $11.00 per share, generating gross proceeds of $125 million. The company intends to use the net proceeds to fund the development of its CAR-T cell therapy NXC-201, working capital, and general corporate purposes.
Inflection Point Acquisition Corp. Viii Capital Raise
Inflection Point Acquisition Corp. VIII announced that holders of the units sold in its initial public offering may elect to separately trade the Class A ordinary shares and warrants starting October 5, 2026. The units were originally issued in an IPO of 28,750,000 units that closed on August 31, 2026. Following separation, the shares and warrants will trade on Nasdaq under the symbols 'IPHX' and 'IPHXW', respectively.
Beasley Broadcast Group completed a registered direct offering and concurrent private placement with a single institutional investor, raising approximately $4.3 million in net proceeds. The offering consisted of 200,000 shares of Class A common stock and pre-funded warrants for 157,000 shares, priced at $14.00 per share/unit. The company intends to use the proceeds to reduce borrowings under its secured asset-based revolving credit facility.
BioStem Technologies entered into a securities purchase agreement with institutional investors for a $3.0 million private placement of 735,296 shares of common stock. The offering includes Series A and Series B warrants to purchase additional shares at an exercise price of $3.83 per share, which could provide an additional $5.6 million if fully exercised. Proceeds are intended for working capital and general corporate purposes.